Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent

K. Ribi; N. Kalbermatten; M. Eicher; F. Strasser

doi:10.1016/j.esmoop.2022.100496

Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent

K. Ribi
, N. Kalbermatten
, M. Eicher
, F. Strasser

Careum School of Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	100496
Journal	ESMO Open
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/j.esmoop.2022.100496
Publication status	Published - 1 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.esmoop.2022.100496

https://linkinghub.elsevier.com/retrieve/pii/S2059702922001168

Cite this

@article{e2870e6fc9864dbcb29c96d89657c489,

title = "Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent",

author = "K. Ribi and N. Kalbermatten and M. Eicher and F. Strasser",

year = "2022",

month = jun,

day = "1",

doi = "10.1016/j.esmoop.2022.100496",

language = "English",

volume = "7",

pages = "100496",

journal = "ESMO Open",

issn = "2059-7029",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent

AU - Ribi, K.

AU - Kalbermatten, N.

AU - Eicher, M.

AU - Strasser, F.

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1016/j.esmoop.2022.100496

DO - 10.1016/j.esmoop.2022.100496

M3 - Article

SN - 2059-7029

VL - 7

SP - 100496

JO - ESMO Open

JF - ESMO Open

IS - 3

ER -